Eli Lilly to buy obesity drugmaker Versanis for nearly $2B :

The Versanis acquisition marks yet another purchase for the dealmaking Lilly, which recently bought Sigilon Therapeutics for $34.6 million upfront and Dice Therapeutics for $2.4 billion.

Related Keywords

United States , Americans , Eli Lilly , Mark Pruzanski , Ruth Gimeno , Sigilon Therapeutics , Bay Area Based Dice Therapeutics ,